Dr Sulaiman Al Habib Medical Services Group (SAU:4013) ROCE %: 13.81% (As of Mar. 2026)


SAU:4013 Dr Sulaiman Al Habib Medical Services Group SAU:4013
92 GF Score
Price ﷼212.80
GF Value ﷼396.06
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Sulaiman Al Habib Medical Services Group ROCE %?

Dr Sulaiman Al Habib Medical Services Group SAU:4013 -0.47% 92 ROCE % is 13.81% as of Mar. 2026. GuruFocus rates SAU:4013 with a GF Score™ of 92/100 and a GF Value™ of ﷼396.06 (Significantly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dr Sulaiman Al Habib Medical Services Group's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.81%.

Dr Sulaiman Al Habib Medical Services Group  (SAU:4013) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dr Sulaiman Al Habib Medical Services Group ROCE % Related Terms

Dr Sulaiman Al Habib Medical Services Group ROCE % Historical Data

* Premium members only.

The historical data trend for Dr Sulaiman Al Habib Medical Services Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Sulaiman Al Habib Medical Services Group ROCE % Chart

Dr Sulaiman Al Habib Medical Services Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 18.58 19.67 19.92 17.83 16.39

Dr Sulaiman Al Habib Medical Services Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.04 16.19 16.21 16.89 13.81
SAU:4013
92GF Score
Dr Sulaiman Al Habib Medical Services Group SAU:4013
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Sulaiman Al Habib Medical Services Group ROCE % Calculation

Dr Sulaiman Al Habib Medical Services Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2858.071/( ( (20557.929 - 4161.806) + (23204.946 - 4718.655) )/ 2 )
=2858.071/( (16396.123+18486.291)/ 2 )
=2858.071/17441.207
=16.39 %

Dr Sulaiman Al Habib Medical Services Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2574.632/( ( (23204.946 - 4718.655) + (23766.27 - 4955.183) )/ 2 )
=2574.632/( ( 18486.291 + 18811.087 )/ 2 )
=2574.632/18648.689
=13.81 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.81% mean?
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a ROCE % of 13.81% as of Mar. 2026.
Is Dr Sulaiman Al Habib Medical Services Group's ROCE % too high?
Dr Sulaiman Al Habib Medical Services Group's current ROCE % is 13.81%. The Healthcare Providers & Services industry median ROCE % is 6.43. Dr Sulaiman Al Habib Medical Services Group's value of 13.81% is 114.8% above this industry median. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's ROCE % compare to HCA and THC?
Dr Sulaiman Al Habib Medical Services Group's ROCE % of 13.81% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. Dr Sulaiman Al Habib Medical Services Group's value of 13.81% is 114.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current ROCE % of 13.81% is 114.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current ROCE % is 13.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼396.06, compared to a current price of ﷼212.80 — trading 46.3% below its estimated fair value. The current ROCE % is 13.81% and 114.8% above the Healthcare Providers & Services industry median of 6.43. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current ROCE % is 13.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued. The current stock price of ﷼212.80 is trading 46.3% below its estimated GF Value™ of ﷼396.06. GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.

Key valuation signals for SAU:4013:

  • ROCE %: 13.81%
  • GF Value™: ﷼396.06 vs. price of ﷼212.80 (46.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs
  • Industry Position: 114.8% above the Healthcare Providers & Services median

No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr Sulaiman Al Habib Medical Services Group Business Description

Address P.O. Box 301578, Al Olaya District, Riyadh, SAU, 11372
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
92GF Score

Get the complete analysis for SAU:4013

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼212.80
Price
﷼396.06
GF Value